ID: ALA5287582

Max Phase: Preclinical

Molecular Formula: C22H25N3O3S

Molecular Weight: 411.53

Associated Items:

Representations

Canonical SMILES:  COc1cc(N(C)CCCO)ccc1/C=C1\C(=O)N(c2ccccc2)C(=S)N1C

Standard InChI:  InChI=1S/C22H25N3O3S/c1-23(12-7-13-26)18-11-10-16(20(15-18)28-3)14-19-21(27)25(22(29)24(19)2)17-8-5-4-6-9-17/h4-6,8-11,14-15,26H,7,12-13H2,1-3H3/b19-14+

Standard InChI Key:  UUFRGRCHCSZSNP-XMHGGMMESA-N

Associated Targets(Human)

NOX4 Tchem NADPH oxidase 4 (333 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYBB Tchem Cytochrome b-245 heavy chain (193 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 411.53Molecular Weight (Monoisotopic): 411.1617AlogP: 3.12#Rotatable Bonds: 7
Polar Surface Area: 56.25Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.91CX LogP: 2.99CX LogD: 2.99
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.56Np Likeness Score: -1.11

References

1. Shim S, Jeong DU, Kim H, Kim CY, Park H, Jin Y, Kim KM, Lee HJ, Kim DH, Bae YS, Choi Y..  (2022)  Discovery of a NADPH oxidase inhibitor, (E)-3-cyclohexyl-5-(4-((2-hydroxyethyl)(methyl)amino)benzylidene)-1-methyl-2-thioxoimidazolidin-4-oneone, as a novel therapeutic for Parkinson's disease.,  244  [PMID:36274279] [10.1016/j.ejmech.2022.114854]

Source